Clinical Trial Update: Trial to Determine Imaging Parameters of LMI1195 in Heart Failure Patients at Low and High Risk of Defibrillator Firing [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating imaging parameters of LMI1195 in heart failure patients at low and high risk of defibrillator firing has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• LMI1195

Snippet

Sponsor: Lantheus Medical Imaging | Conditions: Heart Failure | Phase 2 | Status: WITHDRAWN